11 records – page 1 of 1.

CMA Presentation to the Senate Standing Committee on Social Affairs, Science and Technology - Prescription Drugs: Clinical Trials and Approval

https://policybase.cma.ca/link/policy10437
Date
2012-05-09
Topics
Pharmaceuticals, prescribing, cannabis, drugs

CMA's Submission to the House of Commons Standing Committee on Health: Drug Shortages

https://policybase.cma.ca/link/policy10382
Date
2012-03-29
Topics
Pharmaceuticals, prescribing, cannabis, drugs

CMA's Submission to the Senate Committee on Social Affairs, Science and Technology - Prescription Pharmaceuticals in Canada: The Post-Approval Monitoring of Prescription Pharmaceuticals

https://policybase.cma.ca/link/policy10631
Date
2012-10-24
Topics
Pharmaceuticals, prescribing, cannabis, drugs

Consultation on the prescription drug list: Naloxone

https://policybase.cma.ca/link/policy11847
Date
2016-03-19
Topics
Pharmaceuticals, prescribing, cannabis, drugs

Health Canada’s Consultation on “Plain and Standardized Packaging”

https://policybase.cma.ca/link/policy13817
Date
2016-08-12
Topics
Health care and patient safety
Pharmaceuticals, prescribing, cannabis, drugs

Legalization, regulation and restriction of access to marijuana

https://policybase.cma.ca/link/policy11954
Date
2016-08-29
Topics
Pharmaceuticals, prescribing, cannabis, drugs

Mental Health, Mental Illness & Addiction : CMA Submission to the Standing Committee on Social affairs, Science and Technology

https://policybase.cma.ca/link/policy1950
Last Reviewed
2012-03-03
Date
2005-04-20
Topics
Population health, health equity, public health
Pharmaceuticals, prescribing, cannabis, drugs

National pharmacare in Canada: Getting there from here

https://policybase.cma.ca/link/policy11959
Date
2016-06-01
Topics
Pharmaceuticals, prescribing, cannabis, drugs

Regulation of Self-Care Products in Canada

https://policybase.cma.ca/link/policy13802
Date
2016-10-31
Topics
Pharmaceuticals, prescribing, cannabis, drugs
Health care and patient safety

Regulatory framework for the mandatory reporting of adverse drug reactions and medical device incidents by provincial and territorial healthcare institutions.

https://policybase.cma.ca/link/policy11814
Date
2016-01-20
Topics
Pharmaceuticals, prescribing, cannabis, drugs
Health care and patient safety

Statement to the House of Commons Committee on Health addressing the opioid crisis in Canada

https://policybase.cma.ca/link/policy13936
Date
2016-10-18
Topics
Pharmaceuticals, prescribing, cannabis, drugs
Population health, health equity, public health
Health care and patient safety

11 records – page 1 of 1.